The p53‐specific inhibitor pifithrin‐α prevents diabetic cardiomyopathy by attenuating the early‐stage apoptosis and improving late‐stage defects in glycolysis and angiogenesis
Year: 2017
Type: article
Source: The FASEB Journal
Authors: Junlian Gu, Lu Cai
Institutions: University of Louisville, Kosair Children's Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389019600
